ATF6 Cancer Research Results
ATF6, Activating Transcription Factor 6: Click to Expand ⟱
| Source: |
| Type: protein |
ATF6 (Activating Transcription Factor 6) is a protein that plays a crucial role in the unfolded protein response (UPR), a cellular stress response pathway that is activated in response to endoplasmic reticulum (ER) stress.
High ATF6 expression is associated with poor prognosis, including shorter overall survival and increased risk of recurrence.
|
Scientific Papers found: Click to Expand⟱
*Apoptosis↓, Quercetin can promote the viability, migration and angiogenesis of HBMECs, and inhibit the apoptosis.
*angioG↑,
*NRF2↑, quercetin can also activate Keap1/Nrf2 signaling pathway, reduce ATF6/GRP78 protein expression.
*Keap1↓,
*ATF6↓,
*GRP78/BiP↓,
*CLDN5↑, quercetin could increase the expression of Claudin-5 and Zonula occludens-1.
*ZO-1↑,
*MMP↑, reducing mitochondrial membrane potential damage and inhibiting cell apoptosis.
*BBB↑, quercetin can increase the level of BBB connexin, suggesting that quercetin can maintain BBB integrity.
*ROS↓, Quercetin Could Inhibit Oxidative Stress
*ER Stress↓, In our study, ER stress was activated by H/R, and the levels of ATF6 and GRP78 were increased. Quercetin at 1 μmol/L was able to significantly reduce the protein levels of both, inhibit ER stress, and protect HBMECs from H/R injury
*ER Stress↓, quercetin could inhibit the level of ER stress as evidenced by decreased mRNA expression of PDI, CHOP, GRP78, ATF6, PERK, IRE1α
*PDI↓,
*CHOP↓,
*GRP78/BiP↓,
*ATF6↓,
*PERK↓,
*IRE1↓,
*MMP↑, and improve mitochondrial function, as presented by increased MMP, SOD level and reduced production of ROS, MDA.
*SOD↑,
*ROS↓,
*MDA↓,
*SIRT1↑, quercetin upregulated SIRT1/AMPK mRNA expression.
*AMPK↑,
*Sepsis↓, quercetin could protect against sepsis-induced ALI by suppressing oxidative stress-mediated ER stress and mitochondrial dysfunction via induction of the SIRT1/AMPK pathways.
*GutMicro↑, RA upregulated the abundance of Lactobacillus johnsonii and Candidatus Arthromitus sp SFB-mouse-NL and downregulated the abundance of Bifidobacterium pseudolongum, Escherichia coli, and Romboutsia ilealis.
*ROCK1↓, RA downregulated the expressions of ROCK, RhoA, CaM, MLC, MLCK, ZEB1, ZO-1, ZO-2, occludin, E-cadherin, IL-1β, IL-6, TNF-α, GRP78, PERK, IRE1, ATF6, CHOP, Caspase12, Caspase9, Caspase3, Bax, Cytc, RIPK1, RIPK3, MLKL
*Rho↓,
*CaMKII
↓,
*Zeb1↓,
*ZO-1↓,
*E-cadherin↓,
*IL1β↓,
*IL6↓,
*TNF-α↓,
*GRP78/BiP↓,
*PERK↓,
*IRE1↓,
*ATF6↓,
*CHOP↓,
*Casp12↓,
*Casp9↓,
*BAX↓,
*Casp3↓,
*Cyt‑c↓,
*RIP1↓,
*MLKL↓,
*IL10↑, upregulated the expression of IL-10 and Bcl-2.
*Bcl-2↑,
*ER Stress↓, RA inhibited the inflammation, which is caused by tight junction damage, by repairing intestinal flora dysbiosis, relieved endoplasmic reticulum stress, inhibited cell death
*hepatoP↑, Hepatoprotective benefits of vitamin C against perfluorooctane sulfonate-induced liver damage in mice
*ALAT↓, showed in reductions of serological levels of transaminases (ALT and AST), lipids (TG and TC), fasting glucose and insulin, inflammatory cytokines (TNF-α and IL6)
*AST↓,
*TNF-α↓,
*IL6↓,
*ER Stress↓, Further, intrahepatic expressions of endoplasmic reticulum (ER) stress-based ATF6, eIF2α, GRP78, XBP1 proteins were down-regulated by treatments of VC.
*ATF6↓,
*eIF2α↓,
*GRP78/BiP↓,
*XBP-1↓,
*Inflam↓, suppressing hepatocellular inflammatory reaction and ER stress.
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Total Targets: 0
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
Keap1↓, 1, MDA↓, 1, NRF2↑, 1, ROS↓, 2, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↑, 2,
Core Metabolism/Glycolysis ⓘ
ALAT↓, 1, AMPK↑, 1, SIRT1↑, 1,
Cell Death ⓘ
Apoptosis↓, 1, BAX↓, 1, Bcl-2↑, 1, Casp12↓, 1, Casp3↓, 1, Casp9↓, 1, Cyt‑c↓, 1, MLKL↓, 1, RIP1↓, 1,
Kinase & Signal Transduction ⓘ
CaMKII
↓, 1,
Protein Folding & ER Stress ⓘ
ATF6↓, 4, CHOP↓, 2, eIF2α↓, 1, ER Stress↓, 4, GRP78/BiP↓, 4, IRE1↓, 2, PERK↓, 2, XBP-1↓, 1,
Migration ⓘ
E-cadherin↓, 1, Rho↓, 1, ROCK1↓, 1, Zeb1↓, 1, ZO-1↓, 1, ZO-1↑, 1,
Angiogenesis & Vasculature ⓘ
angioG↑, 1, CLDN5↑, 1, PDI↓, 1,
Barriers & Transport ⓘ
BBB↑, 1,
Immune & Inflammatory Signaling ⓘ
IL10↑, 1, IL1β↓, 1, IL6↓, 2, Inflam↓, 1, TNF-α↓, 2,
Clinical Biomarkers ⓘ
ALAT↓, 1, AST↓, 1, GutMicro↑, 1, IL6↓, 2,
Functional Outcomes ⓘ
hepatoP↑, 1,
Infection & Microbiome ⓘ
Sepsis↓, 1,
Total Targets: 48
Scientific Paper Hit Count for: ATF6, Activating Transcription Factor 6
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:861 State#:% Dir#:1
wNotes=on sortOrder:rid,rpid
Home Page